LOGIN
TEAM
CONTACT US
COLLECTIONS
Bladder
Breast
Leukemia
Pancreas
Pediatric Liver
Sarcoma
HOME
You need to enable JavaScript to run this app page.
Leukemia
TCH-AML002
Model Details
Patient
PDX Model
Metastasis
Patient Treatment
Patient Information for Model: TCH-AML002
Patient Information
Clinical Timeline
Clinical Information at Collection
Clinical Biomarkers/Mutations
Model Information for Model: TCH-AML002
Model Details
Mutations (Cancer Gene Census List)
There are no omics data for this model.
CNV
Metastasis Information for Model: TCH-AML002
Patient
PDX
Central Nervous System
Gingiva
Liver
None
Orbital chloroma
Skin
Spleen
Testis
lymph nodes
retinas
tongue
Patient Treatment Information for Model: TCH-AML002
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Measurable Residual Disease
10
Cytarabine/Idarubicin
De Novo
20.06
0.0
Unknown
Induction Failure
20
Cytarabine/Fludarabine
Refractory
20.25
0.0
Unknown
Residual Disease
30
clo/topotecan/vinorelbine/thiotepa
Refractory
20.37
0.0
Unknown
Residual Disease
40
azacitidine/venetoclax
Refractory
20.54
0.0
Unknown
50
venetoclax
Refractory
20.66
0.0
Unknown
Remission
.16%
70
decitabine/venetoclax then DLI
Relapse
21.3
0.0
Unknown
Relapse
14%
80
decitabine/venetoclax then DLI
Relapse
21.4
0.0
Unknown
Relapse
4%
Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.
Stay Connected
